EndoQuest Robotics
- Company typePrivate
- Founded2022
- HeadquartersHouston, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
EndoQuest Robotics firmographics
Firmographics- Name
- EndoQuest Robotics
- Legal name
- EndoQuest Robotics, Inc.
- Website
- https://endoquestrobotics.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
EndoQuest Robotics industry classification
Industry- Product category
- Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where EndoQuest Robotics is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
EndoQuest Robotics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Endoluminal Surgical System (Hardware + Software): Pre-revenue company. The Endoluminal Surgical System is currently in development and not yet FDA cleared or for commercial sale in the U.S. Revenue will be generated through hardware sales of the robotic surgical system along with associated software, instruments, and consumables to healthcare institutions.
- Service and Support: Expected to include installation, training, maintenance contracts, and technical support services for healthcare institution customers, typical for medical device capital equipment.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
EndoQuest Robotics product offering
Product offeringCore offering
EndoQuest Robotics develops the Endoluminal Surgical (ELS) System, a flexible robotic platform that enables minimally invasive surgery through the body's natural orifices (transoral, transanal, transvaginal) or single-incision (transumbilical) approaches. The integrated system comprises a mobile Patient Cart with the EndoDrive flexible steerable delivery system, 6mm flexible robotic instruments with up to 7 degrees of freedom, a 3.7mm HD robotic camera, and an ergonomic Physician Console with heads-up HD monitor and hand/foot controllers. The product is pre-commercial, currently in U.S. FDA IDE pivotal trials.
Product overview
EndoQuest Robotics offers the Flexible Robotic Surgical System as its core product, a comprehensive platform designed to enable endoluminal and single-incision minimally invasive surgery through natural body orifices or minimal incisions. The system consists of three integrated components: the Patient Cart (featuring the EndoDrive and Removable Touchpad), the Flexible Instruments (with up to 7 degrees of freedom), and the Physician Console (with heads-up HD display and hand controllers). The platform is undergoing clinical development with the PARADIGM pivotal trial and is enhanced with AI-powered capabilities through NVIDIA IGX Thor integration for real-time image processing, tissue differentiation, and cloud intelligence. The company maintains worldwide headquarters in Houston, Texas and a South Korea office. The ELS System is under development and has not been FDA cleared for commercial sale in the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- Endoluminal Surgical (ELS) System A comprehensive flexible robotic surgical platform enabling endoluminal and single-incision procedures through the body's natural orifices (mouth, anus) or transumbilical incision. The integrated system includes a mobile Patient Cart with EndoDrive steerable delivery system, 6mm flexible instruments with up to 7 degrees of freedom, a 3.7mm HD robotic camera, and an ergonomic Physician Console. Designed for hospitals, ambulatory surgical centers, and gastroenterology/colorectal surgeons performing minimally invasive GI and general surgical procedures.
Quantifiable outcome
- First fully robotic endoscopic submucosal dissection (ESD) procedure by a gastroenterologist successfully removed a 4 cm colorectal lesion
Companies that use EndoQuest Robotics
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
EndoQuest Robotics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
EndoQuest Robotics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- NVIDIAcoreEndoQuest expanded collaboration with NVIDIA to integrate AI-powered capabilities into its surgical robotic system. Leveraging NVIDIA's IGX Thor platform for real-time image processing, robotic control, cloud-enabled intelligence, intraoperative tissue differentiation, autonomous surgical tasks, and remote robotic operation capabilities.
- OMNIVISIONcorePartnership to equip the flexible robotic system with industry-leading image sensor technology for enhanced visualization during surgical procedures.
- ProximieminorMulti-year partnership for surgical collaboration and documentation technology integration.
- VirtaMedminorPartnership to develop an endoluminal robotic training simulator for physician education and skill development.
- Brigham and Women's HospitalcoreInstallation of the first Endoluminal Surgical System at Brigham and Women's Hospital in Boston, Massachusetts to advance clinical and procedural development of the ELS System.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
EndoQuest Robotics competitors and assessment
Company assessmentDirect peers
- Moon Surgical: Moon Surgical builds a smaller, flexible robotic surgical assistance platform for laparoscopic procedures, aiming to broaden access to robotic surgery. Comparable in stage and ambition to EndoQuest: a smaller, well-funded surgical robotics entrant focused on novel flexible architectures.
- Asensus Surgical: Asensus Surgical develops the Senhance digital laparoscopic platform and is building a next-gen surgical robotics system with AI-enabled clinical intelligence. Both companies are pursuing digitally enhanced, next-generation minimally invasive surgical systems targeting GI and general surgery.
- Vicarious Surgical: Vicarious Surgical develops single-incision surgical robotics with decoupled actuators for abdominal procedures. Both companies target minimally invasive surgery through small or single incisions using novel robotic architectures, with EndoQuest focused on flexible endoluminal and Vicarious on transabdominal single-port.
Broad incumbents
- Boston Scientific: Boston Scientific has significant GI/endoscopy franchises (including single-use endoscopes and ESD tools) and broader minimally invasive surgery businesses. It is a relevant incumbent and potential acquirer/competitor in the GI endoluminal procedure space.
- Medtronic: Medtronic launched the Hugo robotic-assisted surgery system and has extensive GI/endoscopy businesses (including PillCam and GI solutions). As a broad incumbent, Medtronic competes in both EndoQuest's robotics and downstream GI endoscopy/endoluminal adjacencies.
- Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics company with the da Vinci platform (including the da Vinci SP single-port system). It operates broadly across urology, gynecology, general surgery, and thoracic, with the largest installed base globally and an unmatched clinical evidence library — a clear incumbent benchmark EndoQuest must compete against.
- Stryker: Stryker offers the Mako robotic system for orthopedic surgery and acquired MAKO Surgical and Wright Medical, expanding its surgical robotics presence. While primarily orthopedic-focused, Stryker is a broad surgical robotics incumbent with growing interest in minimally invasive and AI-enabled surgery.
- Olympus Corporation: Olympus is the global leader in GI endoscopy systems and a natural incumbent in flexible endoluminal procedures. While primarily an endoscopy device manufacturer, Olympus has invested in robotic-assisted endoscopy and could expand into endoluminal robotics — directly adjacent to EndoQuest's primary use cases (ESD, myotomy, GI interventions).
- Johnson & Johnson (Ottava / Verb Surgical): Johnson & Johnson is developing the Ottava general surgery robotic platform and acquired Auris Health for Monarch bronchoscopy/endoluminal robotics. As a broad incumbent with substantial R&D resources, J&J represents the most credible threat to extending into flexible endoluminal surgery.
Emerging players
- Medrobotics: Medrobotics developed the Flex Robotic System, a flexible robotic platform for natural orifice procedures (transoral, transanal) — directly comparable endoluminal technology. Although the company has faced restructuring, its technical approach and clinical use cases overlap materially with EndoQuest's platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
EndoQuest Robotics social profiles
Digital presenceEndoQuest Robotics compliance and trust
Trust signalCompliance1 record
EndoQuest Robotics financial estimates
Financial estimateRevenue estimate
Valuation estimate
EndoQuest Robotics leadership team
Management profileNumber of profiles
Profiles6 records
EndoQuest Robotics funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EndoQuest Robotics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EndoQuest Robotics
What does EndoQuest Robotics do?
EndoQuest Robotics develops the Endoluminal Surgical (ELS) System, a flexible robotic platform that enables minimally invasive surgery through the body's natural orifices (transoral, transanal, transvaginal) or single-incision (transumbilical) approaches. The integrated system comprises a mobile Patient Cart with the EndoDrive flexible steerable delivery system, 6mm flexible robotic instruments with up to 7 degrees of freedom, a 3.7mm HD robotic camera, and an ergonomic Physician Console with heads-up HD monitor and hand/foot controllers. The product is pre-commercial, currently in U.S. FDA IDE pivotal trials.
Is EndoQuest Robotics a public or private company?
EndoQuest Robotics is a private company. It is classified as venture growth investor backed and is currently operating.
When was EndoQuest Robotics founded?
EndoQuest Robotics was founded in 2022. It employs 51 to 100 people.
Where is EndoQuest Robotics based?
EndoQuest Robotics is headquartered in Houston, United States, in the North America region.
How does EndoQuest Robotics make money?
Two revenue lines are on record. Endoluminal Surgical System (Hardware + Software) is the primary driver. The others are service and Support.
Who are EndoQuest Robotics's main competitors?
Direct peers on record are Moon Surgical, Asensus Surgical and Vicarious Surgical. Broad incumbents are Boston Scientific, Medtronic, Intuitive Surgical, Stryker, Olympus Corporation and Johnson & Johnson (Ottava / Verb Surgical). Medrobotics is listed as an emerging player.
Does EndoQuest Robotics have an API?
No public API is recorded for EndoQuest Robotics.
What industry is EndoQuest Robotics in?
EndoQuest Robotics's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 339112 and its SIC code is 3841.